Dermapharm Holding SE vs Hypera S.A.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Hypera S.A. is the larger company by market value: $2.5 B against $2.3 B for Dermapharm Holding SE, 1.1 times as much (market caps of Aug 1, 2026 for Dermapharm Holding SE and Nov 19, 2026 for Hypera S.A.). Dermapharm Holding SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Hypera S.A.'s value is an estimate (B3 São Paulo close of 19 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026).
- Hypera S.A. had more revenue: $1.6 B against $1.1 B for Dermapharm Holding SE, both in the year to December 2022.
- Hypera S.A. earned more: net income of $359 M against $148 M for Dermapharm Holding SE.
- Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against 13.1% for Dermapharm Holding SE.
- Hypera S.A. employs more people: 9,000 against 3,497 at Dermapharm Holding SE. Each employee brings in about $322,848 of revenue at Dermapharm Holding SE and $177,222 at Hypera S.A.
- On price to earnings, Dermapharm Holding SE trades at 15.7× and Hypera S.A. at 6.9×: investors pay more for each dollar of Dermapharm Holding SE's profit.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Dermapharm Holding SE DMP.F · #5,838 in the world | Hypera S.A. HYPE3.SA · #5,624 in the world |
|---|---|---|
| Profile | ||
| Country | 🇩🇪 Germany | 🇧🇷 Brazil |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1991 | 2001 |
| Size | ||
| Market cap | $2.3 B | $2.5 B |
| Revenue | $1.1 B | $1.6 B |
| Net income | $148 M | $359 M▲ best |
| Employees | 3,497 | 9,000 |
| Valuation | ||
| P/E ratio | 15.7× | 6.9× |
| Price to sales | 2.1× | 1.6× |
| Price to book | 4.0× | 1.1× |
| Altman Z-score zone | — | — |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Nov 2026 |
Questions and answers#
Which is bigger, Dermapharm Holding SE or Hypera S.A.?
Hypera S.A. is the larger company by market value: $2.5 B against $2.3 B for Dermapharm Holding SE, 1.1 times as much (market caps of Aug 1, 2026 for Dermapharm Holding SE and Nov 19, 2026 for Hypera S.A.). Dermapharm Holding SE's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Hypera S.A.'s value is an estimate (B3 São Paulo close of 19 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026).
Which makes more money, Dermapharm Holding SE or Hypera S.A.?
Hypera S.A. had more revenue: $1.6 B against $1.1 B for Dermapharm Holding SE, both in the year to December 2022. Hypera S.A. earned more: net income of $359 M against $148 M for Dermapharm Holding SE.
Which is more profitable, Dermapharm Holding SE or Hypera S.A.?
Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against 13.1% for Dermapharm Holding SE.
Which has more employees, Dermapharm Holding SE or Hypera S.A.?
Hypera S.A. employs more people: 9,000 against 3,497 at Dermapharm Holding SE. Each employee brings in about $322,848 of revenue at Dermapharm Holding SE and $177,222 at Hypera S.A.
Is Dermapharm Holding SE cheaper than Hypera S.A.?
On price to earnings, Dermapharm Holding SE trades at 15.7× and Hypera S.A. at 6.9×: investors pay more for each dollar of Dermapharm Holding SE's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
More about Dermapharm Holding SE
- Dermapharm Holding SE: company page
- Who owns Dermapharm Holding SE?
- Dermapharm Holding SE market cap history
- Dermapharm Holding SE revenue by year
- How many employees does Dermapharm Holding SE have?
- Is Dermapharm Holding SE cheap or expensive?
- Dermapharm Holding SE against its peers: ranks and percentiles